These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 1378511)

  • 21. Reactivity of two anti-galactosyl ceramide antibodies towards myelin basic protein.
    McLaurin J; Moscarello MA
    J Neurol Sci; 1992 Mar; 108(1):73-9. PubMed ID: 1378088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human megakaryocytes have a CD4 molecule capable of binding human immunodeficiency virus-1.
    Kouri YH; Borkowsky W; Nardi M; Karpatkin S; Basch RS
    Blood; 1993 May; 81(10):2664-70. PubMed ID: 8490176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cells surviving infection by human immunodeficiency virus type 1: vif or vpu mutants produce non-infectious or markedly less cytopathic viruses.
    Kishi M; Nishino Y; Sumiya M; Ohki K; Kimura T; Goto T; Nakai M; Kakinuma M; Ikuta K
    J Gen Virol; 1992 Jan; 73 ( Pt 1)():77-87. PubMed ID: 1730943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A rodent cell line permissive for entry and reverse transcription of human immunodeficiency virus type 1 has a pre-integration block to productive infection.
    Simon JH; Schockmel GA; Illei P; James W
    J Gen Virol; 1994 Oct; 75 ( Pt 10)():2615-23. PubMed ID: 7523578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro.
    Spina CA; Guatelli JC; Richman DD
    J Virol; 1995 May; 69(5):2977-88. PubMed ID: 7707524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Membrane glycolipids and human immunodeficiency virus infection of primary macrophages.
    Seddiki N; Ben Younes-Chennoufi A; Benjouad A; Saffar L; Baumann N; Gluckman JC; Gattegno L
    AIDS Res Hum Retroviruses; 1996 May; 12(8):695-703. PubMed ID: 8744580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of human immunodeficiency virus type 1 (HIV-1) penetration into target cells by synthetic peptides mimicking the N-terminus of the HIV-1 transmembrane glycoprotein.
    Slepushkin VA; Kornilaeva GV; Andreev SM; Sidorova MV; Petrukhina AO; Matsevich GR; Raduk SV; Grigoriev VB; Makarova TV; Lukashov VV
    Virology; 1993 May; 194(1):294-301. PubMed ID: 7683157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergy between human immunodeficiency virus type 1 and Epstein-Barr virus in T lymphoblastoid cell lines.
    Zhang RD; Guan M; Park Y; Tawadros R; Yang JY; Gold B; Wu B; Henderson EE
    AIDS Res Hum Retroviruses; 1997 Jan; 13(2):161-71. PubMed ID: 9007201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The characteristics of human immunodeficiency virus strains isolated from HIV-infected persons on the territory of the USSR].
    Nosik DN; Kalnina LB; Zlobin AIu; Kuznetsova NV; Bochkova MS; Iurin OG; Gushchina EA; Pokrovskiĭ VV; Klimenko SM; L'vov DK
    Vopr Virusol; 1992; 37(1):24-7. PubMed ID: 1384238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of the envelope V3 loop as a determinant of a CD4-negative neuronal cell tropism for HIV-1.
    Trujillo JR; Wang WK; Lee TH; Essex M
    Virology; 1996 Mar; 217(2):613-7. PubMed ID: 8610455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Restriction of HIV-1 replication in intestinal cells is genetically controlled by the gag-pol region of the HIV-1 genome.
    De Mareuil J; Guettari N; Bolmont C; Salaun D; Baillon JG; Hostomsky Z; Hirsch I
    Virology; 1995 Feb; 207(1):160-7. PubMed ID: 7532883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The detection of the human immunodeficiency virus antigen in the lymphoid cells of seropositive subjects].
    Kozlov AP; Emel'ianov AV; Traugott MN; Kurbatova TV; Malykh AG; Kolotvina PV; Peresleni IV; Smirnova TD; Kasatkin VV; Simbirtsev AS
    Vopr Virusol; 1991; 36(3):219-22. PubMed ID: 1716392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibodies to the primary immunodominant domain of human immunodeficiency virus type 1 (HIV-1) glycoprotein gp41 enhance HIV-1 infection in vitro.
    Robinson WE; Kawamura T; Lake D; Masuho Y; Mitchell WM; Hersh EM
    J Virol; 1990 Nov; 64(11):5301-5. PubMed ID: 1698995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Productive infection of CD4+ cells by selected HIV strains is not inhibited by anti-CD4 monoclonal antibodies.
    Rey F; Donker G; Hirsch I; Chermann JC
    Virology; 1991 Mar; 181(1):165-71. PubMed ID: 1704655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benzopurpurin and related compounds inhibit the binding of gp120 to galactosyl ceramide/sulfatide and infection of human immunodeficiency virus.
    Bhat S; Otsuka T; Srinivasan A
    DNA Cell Biol; 1994 Feb; 13(2):211-6. PubMed ID: 8179824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of long-term viral expression in CEM cells persistently infected with non syncytium-inducing HIV-1 strains.
    Yelle J; Morisset R; Thibodeau L
    Arch Virol; 1994; 139(1-2):155-72. PubMed ID: 7826207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication.
    Engelman A; Englund G; Orenstein JM; Martin MA; Craigie R
    J Virol; 1995 May; 69(5):2729-36. PubMed ID: 7535863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody mediated enhancement of HIV-1 infection of an EBV transformed B cell line is CD4 dependent.
    Nottet HS; Janse I; De Vos NM; Bakker LJ; Visser MR; Verhoef J
    Eur J Clin Invest; 1992 Oct; 22(10):670-5. PubMed ID: 1459171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nuclear localization signal of HIV-1 as a novel target for therapeutic intervention.
    Dubrovsky L; Ulrich P; Nuovo GJ; Manogue KR; Cerami A; Bukrinsky M
    Mol Med; 1995 Jan; 1(2):217-30. PubMed ID: 8529100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cloning and characterization of human immunodeficiency virus type 1 variants diminished in the ability to induce syncytium-independent cytolysis.
    Stevenson M; Haggerty S; Lamonica C; Mann AM; Meier C; Wasiak A
    J Virol; 1990 Aug; 64(8):3792-803. PubMed ID: 1695254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.